Pharmaxis Ltd (AU:SNT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd is moving forward with an equity raising initiative, offering fully paid ordinary shares to bolster its financial position. Potential investors should be aware of the significant risks involved, including uncertainties related to clinical trials and business unit sales. The company’s financial future is not guaranteed, and investors are advised to seek professional financial advice.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.